Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease

Therapeutic or Technology

Disease	Cell Type	Therapeutic or Technology	Institution	Project Objective
Traumatic Brain Injury	Embryonic Stem Cell	Exosomes based therapy	UC Irvine	Development Candidate, Proof of Concept, Research Insights
HIV/AIDS, Immune Disease	Adult Stem Cell	Gene-modified, personalized cell therapy	UCSF	Clinical Trial, Phase 1 or Phase 1/2
Spina Bifida	Adult Stem Cell	Donor cell therapy	UC Davis	Clinical Trial, Phase 1 or Phase 1/2
Sickle Cell Disease	Adult Stem Cell	Gene-modified, personalized cell therapy	Boston Children's Hospital	Clinical Trial, Phase 2
Beta Thalassemia, Sickle Cell Disease	Adult Stem Cell	Diagnostic Test	UCSF	Regulated Lab Test, Ready for Validation
Leukemia, Acute Myeloid (AML)	Cancer Stem Cell	Antibody	Immune-Onc Therapeutics	Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer	Adult Stem Cell	Gene-modified, personalized cell therapy	COH	Clinical Trial, Phase 1 or Phase 1/2
Multiple Myeloma	Adult Stem Cell	Gene-modified, donor cell therapy	UCLA	Pre-IND/IDE or Equivalent
Melanoma	Adult Stem Cell	Gene-modified, personalized cell therapy	UCLA	Pre-IND/IDE or Equivalent
Amyotrophic Lateral Sclerosis	Adult Stem Cell	Gene-modified, donor cell therapy	Cedars-Sinai	Clinical Trial, Phase 1 or Phase 1/2
Stroke	Embryonic Stem Cell	Donor cell therapy	Stanford	Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer	Adult Stem Cell	Gene-modified, personalized cell therapy	Stanford	Clinical Trial, Phase 1 or Phase 1/2
Heart failure	Embryonic Stem Cell	Donor cell therapy	Stanford	Clinical Trial, Phase 1 or Phase 1/2
Heart Disease	iPS Cell	Donor cell therapy	UC Davis	Development Candidate, Proof of Concept
Pancreatic Cancer	Cancer Stem Cell	Small molecule therapy	UCSD	Development Candidate, Proof of Concept
Liver Disease	iPS Cell	Diagnostic Test	UCSF	Development Candidate, Proof of Concept
Brain Cancer, Neurological Disorders	Embryonic Stem Cell	Exosomes based therapy	UC Irvine	Development Candidate, Proof of Concept
Anemia	Adult Stem Cell, iPS Cell	Small molecule therapy	Stanford	Development Candidate, Proof of Concept
Heart failure	iPS Cell	Exosomes based therapy	Stanford	Development Candidate, Proof of Concept
Angelman Syndrome, Autism	iPS Cell	Gene Therapy, cell free	UC Davis	Development Candidate, Proof of Concept
Epidermolysis Bullosa	iPS Cell	Gene-modified, personalized cell therapy	Stanford	Development Candidate, Proof of Concept
Ovarian Cancer	iPS Cell	Gene-modified, donor cell therapy	UCSD	Development Candidate, Proof of Concept
Amyotrophic Lateral Sclerosis	Adult Stem Cell	Donor cell therapy	UCSD	Development Candidate, Proof of Concept
Heart Disease	iPS Cell	Model system development	Stanford	Development Candidate, Proof of Concept
Sickle Cell Disease	Adult Stem Cell	Gene-modified, personalized cell therapy	UCSF	Clinical Trial, Phase 1 or Phase 1/2
B cell cancers, Leukemia, Leukemia, Acute Myeloid (AML)	Adult Stem Cell	Donor cell therapy	Stanford	Clinical Trial, Phase 1 or Phase 1/2
Cartilage defect	Embryonic Stem Cell	Donor cell therapy	USC	IND
Blood Cancer	Adult Stem Cell	Gene-modified, personalized cell therapy	UCSD	IND
Muscular Dystrophy		Protein/peptide therapy	Juvena Therapeutics Inc.	Pre-IND/IDE or Equivalent
Stroke	iPS Cell	Donor cell therapy	UCLA	Pre-IND/IDE or Equivalent
Heart Disease	Adult Stem Cell	Antibody	UCLA	Pre-IND/IDE or Equivalent
IPEX Syndrome	Adult Stem Cell	Gene-modified, personalized cell therapy	ImmunoVec	Pre-IND/IDE or Equivalent
Brain Cancer	Somatic Cell	Gene-modified, personalized cell therapy	UCSF	Pre-IND/IDE or Equivalent
Heart Disease	iPS Cell	Protein/peptide therapy	Regencor, Inc.	Pre-IND/IDE or Equivalent
Metabolic Disorders	Somatic Cell	Gene-modified, personalized cell therapy	Immusoft Corporation	Pre-IND/IDE or Equivalent
Duchenne Muscular Dystrophy	Somatic Cell	Gene Therapy, cell free	MyoGene Bio LLC	Pre-IND/IDE or Equivalent
B cell cancers	Somatic Cell	Gene-modified, personalized cell therapy	UCSF	Pre-IND/IDE or Equivalent
Spinal Cord Injury	Adult Stem Cell	Donor cell therapy	UC Irvine	Pre-IND/IDE or Equivalent
Heart Disease	iPS Cell	Model system development	Organos, Inc.	Tool/Resources/Bottleneck
Heart failure	Adult Stem Cell	Nucleic acid based therapy	Cedars-Sinai	Development Candidate, Proof of Concept
Neurological Disorders	iPS Cell	Gene Therapy, cell free	Navega Therapeutics	Development Candidate, Proof of Concept
Spinal Cord Injury	iPS Cell	Other Components	Stanford	Development Candidate, Proof of Concept
Multiple Myeloma	Somatic Cell	Gene-modified, personalized cell therapy	UCSF	Development Candidate, Proof of Concept
Multiple Sclerosis	Adult Stem Cell	Small molecule therapy	Scripps	Development Candidate, Proof of Concept
Kidney Disease	Somatic Cell	Gene Therapy, cell free	UCSF	Development Candidate, Proof of Concept
Neurological Disorders, Sanfilippo Syndrome/MPS III	iPS Cell	Gene-modified, personalized cell therapy	UC Irvine	Development Candidate, Proof of Concept
Huntington's Disease	iPS Cell	Gene Therapy, cell free	UCSD	Development Candidate, Proof of Concept
Cartilage defect	Adult Stem Cell	Biologic	The Stone Research Foundation for Sports Medicine and Arthritis	Development Candidate, Proof of Concept
Cartilage defect, Osteoarthritis	Embryonic Stem Cell	Donor cell therapy	Scripps Health	Development Candidate, Proof of Concept
Type 1 diabetes	Embryonic Stem Cell, iPS Cell	Biologic	UCLA	Development Candidate, Proof of Concept

California's Stem Cell Agency

California Institute for Regenerative Medicine

Active Awards Portfolio Dashboard

Filter Awards

Pages

aa Multiple Diseases (Centers & Resoures)
Aging
– Arthritis
Blood Disorders
– Alpha Thalassemia Major
– Anemia
– Beta Thalassemia
– Bone Marrow Transplant and Viral Infection
– Hemophilia A
– Hyper IgM Syndrome
– IPEX Syndrome
– Leukocyte Adhesion Deficiency
– Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
– Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
– Severe Combined Immunodeficiency, X-linked (X-SCID)
– Sickle Cell Disease
– X-linked Chronic Granulomatous Disease
Bone or Cartilage Disease
– Cartilage defect
– Intervertebral disc degeneration
– Osteoarthritis
– Osteonecrosis
– Osteoporosis, malignant infantile
– Tendon/Ligament/Connective Tissue Injury or Disorder
Cancer
– Blood Cancer
–– Acute Myeloid Leukemia
–– B cell cancers
–– HIV-related Lymphoma
–– Leukemia
–– Leukemia, Acute Myeloid (AML)
–– Multiple Myeloma
– Solid Tumors
–– Brain Cancer
–– Breast Cancer
–– Colon Cancer
–– Lung Cancer
–– Melanoma
–– Ovarian Cancer
–– Pancreatic Cancer
–– Prostate Cancer
–– Sarcoma
–– Skin cancer
Developmental Disorders
Fertility
Genetic Disorder
Hearing Loss
Heart Disease
– Heart disease associated with Duchenne muscular dystrophy
– Heart failure
– Pulmonary Hypertension
–– Hypertension, pulmonary arterial
Immune Disease
– Thymic Disorder, 22q11 Deletion/DiGeorge
Incontinence
Infectious Disease
– COVID-19
– HIV/AIDS
– Zika virus
Kidney Disease
– Kidney Failure
Metabolic Disorders
– Cystinosis
– Danon Disease
– Diabetes
–– Diabetic Wounds
–– Type 1 diabetes
– Intestinal Disease
–– Inflammatory bowel disease
– Liver Disease
– Sanfilippo Syndrome/MPS III
Multiple Indications (Alpha Clinics)
Neurological Disorders
– Alzheimer's Disease
– Amyotrophic Lateral Sclerosis
– Angelman Syndrome
– Autism
– Brain Injury, hypoxic, ischemic
– Canavan Disease
– Dementia
– Epilepsy
– Huntington's Disease
– Intellectual Disability
– Multiple Sclerosis
– Neuropathy
– Parkinson's Disease
– Rett's Syndrome
– Spina Bifida
– Spinal Cord Injury
– Spinal Muscular Atrophy
– Stroke
– Traumatic Brain Injury
Other
Pediatrics
Respiratory Disorders
– Cystic Fibrosis
– Lung Disease, Fibrosis
Skeletal/Smooth Muscle disorders
– Bladder or Urinary Tract Disorder
– Duchenne Muscular Dystrophy
– Muscle Injury
– Muscular Dystrophy
Skin Disease
– Epidermolysis Bullosa
– Wounds, ulcers
Toxicity
Trauma
Vascular Disease
Vision Loss
– Age-related macular degeneration
– Corneal Damage
– Retinitis Pigmentosa

Therapeutic Approach
– Biologic
–– Antibody
–– Convalescent Plasma
–– Exosomes based therapy
–– Gene modification
–– Nucleic acid based therapy
–– Protein/peptide therapy
–– Vaccine
– Gene Therapy (All)
–– Gene Therapy, cell free
–– Gene-modified, donor cell therapy
–– Gene-modified, personalized cell therapy
– Small molecule therapy
– Device
– Donor cell therapy
– Personalized cell therapy
– Other Components
Technology
– Assay development
– Bioinformatics/Computational Tools
– Cell Line Generation-Resource
– Diagnostic Test
– Gene editing tools
– Cell delivery or targeting
– Cell imaging & tracking
– Cell processing & handling
– Exploring disease mechanisms
– Exploring stem cell mechanisms
– Immune tolerance/management
– Model system development
– Specific Cell Type Derivation
– Therapeutic target discovery
– Tissue engineering